NEW YORK, May 29, 2023 /PRNewswire/ — The Klein Law Firm announces that it is investigating allegations that Reata Pharmaceuticals, Inc. (“Reata” or “the Company”) (NASDAQ: RETA) violated federal securities laws. CURRENT INVESTIGATION DETAILS: On May 10, 2023, Reata issued a press release announcing its financial results for the first…Read More
RETA NEWS The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Reata Pharmaceuticals Inc MarketScreener
